APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade CBD Oil

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032

Report ID 174024850131 December 2025112 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade CBD Oil Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade CBD Oil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Grade CBD Oil include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Grade CBD Oil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Grade CBD Oil market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Grade CBD Oil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Grade CBD Oil.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharmaceutical Grade CBD Oil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Grade CBD Oil Market by Company

Absolute Terps

Aphria

Cannavest

Canopy Growth Corporation

CBD American Shaman

Charlotte's Web

Emblem Cannabis Oils

ENDOCA

Folium Biosciences

GL Brands, Inc.

Green Road

HempLife Today

K.I.N.D. Concentrates

Kazmira

Medical Marijuana, Inc.

NuLeaf Naturals

PHARM-CBD, LLC

The Lab

Whistler

Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil

Broad Spectrum CBD Oil

Pharmaceutical Grade CBD Oil Segment by Application

Anxiety

Diabetes

Fibromyalgia

Others

Pharmaceutical Grade CBD Oil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Full Spectrum CBD Oil Table 2. Major Company of Broad Spectrum CBD Oil Table 3. Global Pharmaceutical Grade CBD Oil Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 5. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type (2021-2026) Table 8. Global Pharmaceutical Grade CBD Oil Price by Type (2021-2026) & (US$/Kg) Table 9. Global Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 10. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type (2027-2032) Table 13. Global Pharmaceutical Grade CBD Oil Price by Type (2027-2032) & (US$/Kg) Table 14. North America Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 15. North America Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 17. Europe Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 21. Latin America Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (US$ Million) Table 24. Pharmaceutical Grade CBD Oil Industry Trends Table 25. Pharmaceutical Grade CBD Oil Industry Drivers Table 26. Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges Table 27. Pharmaceutical Grade CBD Oil Industry Restraints Table 28. Global Pharmaceutical Grade CBD Oil Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Company (2021-2026) Table 30. Global Pharmaceutical Grade CBD Oil Sales by Company (2021-2026) & (Tons) Table 31. Global Pharmaceutical Grade CBD Oil Sales Share by Company (2021-2026) Table 32. Global Pharmaceutical Grade CBD Oil Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Pharmaceutical Grade CBD Oil Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pharmaceutical Grade CBD Oil Major Company Production Sites and Headquarters Table 35. Global Pharmaceutical Grade CBD Oil Company, Product Type & Application Table 36. Global Pharmaceutical Grade CBD Oil Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pharmaceutical Grade CBD Oil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pharmaceutical Grade CBD Oil Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (Tons) Table 41. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Region (2021-2026) Table 44. Global Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032) & (Tons) Table 46. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Region (2027-2032) Table 49. Global Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Pharmaceutical Grade CBD Oil Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 52. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application (2021-2026) Table 55. Global Pharmaceutical Grade CBD Oil Price by Application (2021-2026) & (US$/Kg) Table 56. Global Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 57. Global Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application (2027-2032) Table 60. Global Pharmaceutical Grade CBD Oil Price by Application (2027-2032) & (US$/Kg) Table 61. North America Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 62. North America Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 64. Europe Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 68. Latin America Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (US$ Million) Table 71. Absolute Terps Company Information Table 72. Absolute Terps Business Overview Table 73. Absolute Terps Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio Table 75. Absolute Terps Recent Development Table 76. Aphria Company Information Table 77. Aphria Business Overview Table 78. Aphria Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Aphria Pharmaceutical Grade CBD Oil Product Portfolio Table 80. Aphria Recent Development Table 81. Cannavest Company Information Table 82. Cannavest Business Overview Table 83. Cannavest Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Cannavest Pharmaceutical Grade CBD Oil Product Portfolio Table 85. Cannavest Recent Development Table 86. Canopy Growth Corporation Company Information Table 87. Canopy Growth Corporation Business Overview Table 88. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio Table 90. Canopy Growth Corporation Recent Development Table 91. CBD American Shaman Company Information Table 92. CBD American Shaman Business Overview Table 93. CBD American Shaman Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio Table 95. CBD American Shaman Recent Development Table 96. Charlotte's Web Company Information Table 97. Charlotte's Web Business Overview Table 98. Charlotte's Web Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio Table 100. Charlotte's Web Recent Development Table 101. Emblem Cannabis Oils Company Information Table 102. Emblem Cannabis Oils Business Overview Table 103. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio Table 105. Emblem Cannabis Oils Recent Development Table 106. ENDOCA Company Information Table 107. ENDOCA Business Overview Table 108. ENDOCA Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio Table 110. ENDOCA Recent Development Table 111. Folium Biosciences Company Information Table 112. Folium Biosciences Business Overview Table 113. Folium Biosciences Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio Table 115. Folium Biosciences Recent Development Table 116. GL Brands, Inc. Company Information Table 117. GL Brands, Inc. Business Overview Table 118. GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 120. GL Brands, Inc. Recent Development Table 121. Green Road Company Information Table 122. Green Road Business Overview Table 123. Green Road Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Green Road Pharmaceutical Grade CBD Oil Product Portfolio Table 125. Green Road Recent Development Table 126. HempLife Today Company Information Table 127. HempLife Today Business Overview Table 128. HempLife Today Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio Table 130. HempLife Today Recent Development Table 131. K.I.N.D. Concentrates Company Information Table 132. K.I.N.D. Concentrates Business Overview Table 133. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio Table 135. K.I.N.D. Concentrates Recent Development Table 136. Kazmira Company Information Table 137. Kazmira Business Overview Table 138. Kazmira Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Kazmira Pharmaceutical Grade CBD Oil Product Portfolio Table 140. Kazmira Recent Development Table 141. Medical Marijuana, Inc. Company Information Table 142. Medical Marijuana, Inc. Business Overview Table 143. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 144. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 145. Medical Marijuana, Inc. Recent Development Table 146. NuLeaf Naturals Company Information Table 147. NuLeaf Naturals Business Overview Table 148. NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 149. NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio Table 150. NuLeaf Naturals Recent Development Table 151. PHARM-CBD, LLC Company Information Table 152. PHARM-CBD, LLC Business Overview Table 153. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 154. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio Table 155. PHARM-CBD, LLC Recent Development Table 156. The Lab Company Information Table 157. The Lab Business Overview Table 158. The Lab Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 159. The Lab Pharmaceutical Grade CBD Oil Product Portfolio Table 160. The Lab Recent Development Table 161. Whistler Company Information Table 162. Whistler Business Overview Table 163. Whistler Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 164. Whistler Pharmaceutical Grade CBD Oil Product Portfolio Table 165. Whistler Recent Development Table 166. North America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 167. North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 168. North America Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 169. North America Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032) & (Tons) Table 170. North America Pharmaceutical Grade CBD Oil Sales Market Share Forecast by Country (2027-2032) Table 171. North America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Pharmaceutical Grade CBD Oil Market Share by Country (2021-2026) Table 174. North America Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Pharmaceutical Grade CBD Oil Market Share Forecast by Country (2027-2032) Table 176. Europe Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 177. Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 178. Europe Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 179. Europe Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032) & (Tons) Table 180. Europe Pharmaceutical Grade CBD Oil Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Pharmaceutical Grade CBD Oil Market Share by Country (2021-2026) Table 184. Europe Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Pharmaceutical Grade CBD Oil Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 188. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032) & (Tons) Table 190. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Pharmaceutical Grade CBD Oil Market Share by Country (2021-2026) Table 194. Asia-Pacific Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Pharmaceutical Grade CBD Oil Market Share Forecast by Country (2027-2032) Table 196. Latin America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 197. Latin America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 198. Latin America Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 199. Latin America Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032) & (Tons) Table 200. Latin America Pharmaceutical Grade CBD Oil Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Pharmaceutical Grade CBD Oil Market Share by Country (2021-2026) Table 204. Latin America Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Pharmaceutical Grade CBD Oil Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 208. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032) & (Tons) Table 210. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Pharmaceutical Grade CBD Oil Market Share by Country (2021-2026) Table 214. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Pharmaceutical Grade CBD Oil Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Pharmaceutical Grade CBD Oil Distributors List Table 219. Pharmaceutical Grade CBD Oil Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Pharmaceutical Grade CBD Oil Image Figure 2. Global Pharmaceutical Grade CBD Oil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade CBD Oil Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade CBD Oil Sales (2021-2032) & (Tons) Figure 5. Full Spectrum CBD Oil Image Figure 6. Global Full Spectrum CBD Oil Sales YoY Growth (2021-2032) & (Tons) Figure 7. Broad Spectrum CBD Oil Image Figure 8. Global Broad Spectrum CBD Oil Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Pharmaceutical Grade CBD Oil Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pharmaceutical Grade CBD Oil Market Share by Type 2025 VS 2032 Figure 11. North America Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type in 2025 Figure 12. North America Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type in 2025 Figure 13. Europe Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Anxiety Image Figure 24. Global Anxiety Sales YoY Growth (2021-2032) & (Tons) Figure 25. Diabetes Image Figure 26. Global Diabetes Sales YoY Growth (2021-2032) & (Tons) Figure 27. Fibromyalgia Image Figure 28. Global Fibromyalgia Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Pharmaceutical Grade CBD Oil Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pharmaceutical Grade CBD Oil Market Share by Application 2025 VS 2032 Figure 33. North America Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application in 2025 Figure 34. North America Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application in 2025 Figure 35. Europe Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share in Value by Application in 2025 Figure 43. North America Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Pharmaceutical Grade CBD Oil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pharmaceutical Grade CBD Oil Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Pharmaceutical Grade CBD Oil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pharmaceutical Grade CBD Oil Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pharmaceutical Grade CBD Oil Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Pharmaceutical Grade CBD Oil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pharmaceutical Grade CBD Oil Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pharmaceutical Grade CBD Oil Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pharmaceutical Grade CBD Oil Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pharmaceutical Grade CBD Oil Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
Applications
  • Anxiety
  • Diabetes
  • Fibromyalgia
  • Others
Companies covered
  • Absolute Terps
  • Aphria
  • Cannavest
  • Canopy Growth Corporation
  • CBD American Shaman
  • Charlotte's Web
  • Emblem Cannabis Oils
  • ENDOCA
  • Folium Biosciences
  • GL Brands, Inc.
  • Green Road
  • HempLife Today
  • K.I.N.D. Concentrates
  • Kazmira
  • Medical Marijuana, Inc.
  • NuLeaf Naturals
  • PHARM-CBD, LLC
  • The Lab
  • Whistler

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade CBD Oil Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade CBD Oil Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharmaceutical Grade CBD Oil Market by Type
  6. 1.3.1 Full Spectrum CBD Oil
  7. 1.3.2 Broad Spectrum CBD Oil
  8. 1.4 Global Pharmaceutical Grade CBD Oil Market Size by Type
  9. 1.4.1 Global Pharmaceutical Grade CBD Oil Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pharmaceutical Grade CBD Oil Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pharmaceutical Grade CBD Oil Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pharmaceutical Grade CBD Oil Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pharmaceutical Grade CBD Oil Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pharmaceutical Grade CBD Oil Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pharmaceutical Grade CBD Oil Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharmaceutical Grade CBD Oil Industry Trends
  2. 2.2 Pharmaceutical Grade CBD Oil Industry Drivers
  3. 2.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade CBD Oil Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharmaceutical Grade CBD Oil Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharmaceutical Grade CBD Oil Sales (2021-2026)
  3. 3.3 Global Top Players by Pharmaceutical Grade CBD Oil Price (2021-2026)
  4. 3.4 Global Pharmaceutical Grade CBD Oil Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Grade CBD Oil Major Company Production Sites & Headquarters
  6. 3.6 Global Pharmaceutical Grade CBD Oil Company, Product Type & Application
  7. 3.7 Global Pharmaceutical Grade CBD Oil Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Grade CBD Oil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Grade CBD Oil Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade CBD Oil Regional Status and Outlook
  1. 4.1 Global Pharmaceutical Grade CBD Oil Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharmaceutical Grade CBD Oil Historic Market Size by Region
  3. 4.2.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharmaceutical Grade CBD Oil Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharmaceutical Grade CBD Oil Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharmaceutical Grade CBD Oil Forecasted Market Size by Region
  7. 4.3.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharmaceutical Grade CBD Oil Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharmaceutical Grade CBD Oil Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharmaceutical Grade CBD Oil by Application
  1. 5.1 Pharmaceutical Grade CBD Oil Market by Application
  2. 5.1.1 Anxiety
  3. 5.1.2 Diabetes
  4. 5.1.3 Fibromyalgia
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Grade CBD Oil Market Size by Application
  7. 5.2.1 Global Pharmaceutical Grade CBD Oil Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pharmaceutical Grade CBD Oil Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pharmaceutical Grade CBD Oil Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pharmaceutical Grade CBD Oil Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pharmaceutical Grade CBD Oil Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pharmaceutical Grade CBD Oil Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pharmaceutical Grade CBD Oil Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Absolute Terps
  2. 6.1.1 Absolute Terps Company Information
  3. 6.1.2 Absolute Terps Business Overview
  4. 6.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
  6. 6.1.5 Absolute Terps Recent Developments
  7. 6.2 Aphria
  8. 6.2.1 Aphria Company Information
  9. 6.2.2 Aphria Business Overview
  10. 6.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
  12. 6.2.5 Aphria Recent Developments
  13. 6.3 Cannavest
  14. 6.3.1 Cannavest Company Information
  15. 6.3.2 Cannavest Business Overview
  16. 6.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
  18. 6.3.5 Cannavest Recent Developments
  19. 6.4 Canopy Growth Corporation
  20. 6.4.1 Canopy Growth Corporation Company Information
  21. 6.4.2 Canopy Growth Corporation Business Overview
  22. 6.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
  24. 6.4.5 Canopy Growth Corporation Recent Developments
  25. 6.5 CBD American Shaman
  26. 6.5.1 CBD American Shaman Company Information
  27. 6.5.2 CBD American Shaman Business Overview
  28. 6.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
  30. 6.5.5 CBD American Shaman Recent Developments
  31. 6.6 Charlotte's Web
  32. 6.6.1 Charlotte's Web Company Information
  33. 6.6.2 Charlotte's Web Business Overview
  34. 6.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
  36. 6.6.5 Charlotte's Web Recent Developments
  37. 6.7 Emblem Cannabis Oils
  38. 6.7.1 Emblem Cannabis Oils Company Information
  39. 6.7.2 Emblem Cannabis Oils Business Overview
  40. 6.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
  42. 6.7.5 Emblem Cannabis Oils Recent Developments
  43. 6.8 ENDOCA
  44. 6.8.1 ENDOCA Company Information
  45. 6.8.2 ENDOCA Business Overview
  46. 6.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
  48. 6.8.5 ENDOCA Recent Developments
  49. 6.9 Folium Biosciences
  50. 6.9.1 Folium Biosciences Company Information
  51. 6.9.2 Folium Biosciences Business Overview
  52. 6.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
  54. 6.9.5 Folium Biosciences Recent Developments
  55. 6.10 GL Brands, Inc.
  56. 6.10.1 GL Brands, Inc. Company Information
  57. 6.10.2 GL Brands, Inc. Business Overview
  58. 6.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  60. 6.10.5 GL Brands, Inc. Recent Developments
  61. 6.11 Green Road
  62. 6.11.1 Green Road Company Information
  63. 6.11.2 Green Road Business Overview
  64. 6.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
  66. 6.11.5 Green Road Recent Developments
  67. 6.12 HempLife Today
  68. 6.12.1 HempLife Today Company Information
  69. 6.12.2 HempLife Today Business Overview
  70. 6.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
  72. 6.12.5 HempLife Today Recent Developments
  73. 6.13 K.I.N.D. Concentrates
  74. 6.13.1 K.I.N.D. Concentrates Company Information
  75. 6.13.2 K.I.N.D. Concentrates Business Overview
  76. 6.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
  78. 6.13.5 K.I.N.D. Concentrates Recent Developments
  79. 6.14 Kazmira
  80. 6.14.1 Kazmira Company Information
  81. 6.14.2 Kazmira Business Overview
  82. 6.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
  84. 6.14.5 Kazmira Recent Developments
  85. 6.15 Medical Marijuana, Inc.
  86. 6.15.1 Medical Marijuana, Inc. Company Information
  87. 6.15.2 Medical Marijuana, Inc. Business Overview
  88. 6.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  90. 6.15.5 Medical Marijuana, Inc. Recent Developments
  91. 6.16 NuLeaf Naturals
  92. 6.16.1 NuLeaf Naturals Company Information
  93. 6.16.2 NuLeaf Naturals Business Overview
  94. 6.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
  96. 6.16.5 NuLeaf Naturals Recent Developments
  97. 6.17 PHARM-CBD, LLC
  98. 6.17.1 PHARM-CBD, LLC Company Information
  99. 6.17.2 PHARM-CBD, LLC Business Overview
  100. 6.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
  102. 6.17.5 PHARM-CBD, LLC Recent Developments
  103. 6.18 The Lab
  104. 6.18.1 The Lab Company Information
  105. 6.18.2 The Lab Business Overview
  106. 6.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
  108. 6.18.5 The Lab Recent Developments
  109. 6.19 Whistler
  110. 6.19.1 Whistler Company Information
  111. 6.19.2 Whistler Business Overview
  112. 6.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
  114. 6.19.5 Whistler Recent Developments
7 North America by Country
  1. 7.1 North America Pharmaceutical Grade CBD Oil Sales by Country
  2. 7.1.1 North America Pharmaceutical Grade CBD Oil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  4. 7.1.3 North America Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharmaceutical Grade CBD Oil Market Size by Country
  6. 7.2.1 North America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharmaceutical Grade CBD Oil Sales by Country
  2. 8.1.1 Europe Pharmaceutical Grade CBD Oil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharmaceutical Grade CBD Oil Market Size by Country
  6. 8.2.1 Europe Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Country
  2. 9.1.1 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharmaceutical Grade CBD Oil Market Size by Country
  6. 9.2.1 Asia-Pacific Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharmaceutical Grade CBD Oil Sales by Country
  2. 10.1.1 South America Pharmaceutical Grade CBD Oil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  4. 10.1.3 South America Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharmaceutical Grade CBD Oil Market Size by Country
  6. 10.2.1 South America Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country
  2. 11.1.1 Middle East and Africa Pharmaceutical Grade CBD Oil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharmaceutical Grade CBD Oil Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country
  6. 11.2.1 Middle East and Africa Pharmaceutical Grade CBD Oil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharmaceutical Grade CBD Oil Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
  2. 12.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharmaceutical Grade CBD Oil Production Mode & Process
  7. 12.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharmaceutical Grade CBD Oil Distributors
  10. 12.2.3 Pharmaceutical Grade CBD Oil Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst